Global Surveillance for Meningococcal Disease

  • Nancy E. Rosenstein
Part of the Methods in Molecular Medicine™ book series (MIMM, volume 67)

Abstract

The word “surveillance” probably first referred to close supervision of individuals exposed to an infectious disease and their close contacts (1). Currently, though, surveillance refers more frequently to the ongoing accumulation of data so that it can be used for decision-making. A surveillance system includes collection, analysis, and dissemination of data. Surveillance can be used to evaluate trends in disease, to identify outbreaks, to test hypotheses, to evaluate existing programs, and to plan for new programs. Surveillance is the single most important tool for identifying infectious diseases that are emerging, are causing serious public health problems, or are diminishing in importance (2).

Keywords

Assure Meningitis Purpura 

References

  1. 1.
    Thacker S. B. and Berkelman R. L. (1988) Public health surveillance in the United States. Epidemiol. Rev. 10, 164–190.PubMedGoogle Scholar
  2. 3.
    Murray C. J. L. and Lopez A. D. (1996) Anonymous Global Health Statistics: a compendium of incidence, prevalence, and mortality estimates for over 200 conditions. The Harvard School of Public Health on behalf of The World Health Organization and the World Bank Boston, 283–309.Google Scholar
  3. 4.
    World Health Organization (1996) Cerebrospinal meningitis in Africa. Wkly.Epidemiol. Rep. 42, 318–319.Google Scholar
  4. 5.
    World Health Organization (1997) Epidemic meningitis in Africa, 1997. Wkly.Epidemiol. Rep. 42, 314–318.Google Scholar
  5. 6.
    Centers for Disease Control and Prevention (1997) Case definitions for infectious conditions under public health surveillance. MMWR 46(RR-10), 1–55.Google Scholar
  6. 7.
    World Health Organization Working Group (1995) Control of epidemic meningococcal diseases. WHO Practical Guidelines. Edition Fondation Marcel Merieux Lyon, France.Google Scholar
  7. 8.
    Effler P., Ching-Lee M., Bogard A., et al. (1999) Statewide system of electronic notifiable disease reporting from clinical laboratories. JAMA 282, 1845–1850.CrossRefPubMedGoogle Scholar
  8. 9.
    Centers for Disease Control and Prevention (1998) Guidelines for evaluating surveillance systems. MMWR 37, 1–18.Google Scholar
  9. 9.
    Centers for Disease Control and Prevention (1998)Guidelines for evaluating surveillance systems.MMWR 37,1–18.Google Scholar
  10. 10.
    Centers for Disease Control and Prevention (1997) Control and prevention of meningococcal disease and Control and prevention of serogroup C meningococcal disease: evaluation and management of suspected outbreaks. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 46(RR-5), 1–21.Google Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2001

Authors and Affiliations

  • Nancy E. Rosenstein
    • 1
  1. 1.Division of Bacterial and Mycotic Diseases, Meningitis and Special Pathogens BranchNational Center for Infectious Diseases, Centers for Disease Control and PreventionAtlanta

Personalised recommendations